1.27
Geron Corp stock is traded at $1.27, with a volume of 11.92M.
It is down -3.05% in the last 24 hours and up +0.00% over the past month.
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
See More
Previous Close:
$1.31
Open:
$1.33
24h Volume:
11.92M
Relative Volume:
1.44
Market Cap:
$810.28M
Revenue:
$29.48M
Net Income/Loss:
$-201.19M
P/E Ratio:
-3.9688
EPS:
-0.32
Net Cash Flow:
$-216.50M
1W Performance:
-0.78%
1M Performance:
+0.00%
6M Performance:
-7.97%
1Y Performance:
-70.67%
Geron Corp Stock (GERN) Company Profile
Name
Geron Corp
Sector
Industry
Phone
(650) 473-7700
Address
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Compare GERN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
GERN
Geron Corp
|
1.27 | 835.80M | 29.48M | -201.19M | -216.50M | -0.32 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Geron Corp Stock (GERN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-10-25 | Resumed | Goldman | Sell |
May-08-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
Feb-27-25 | Downgrade | B. Riley Securities | Buy → Neutral |
Feb-26-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
Nov-05-24 | Initiated | H.C. Wainwright | Buy |
Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
Sep-09-24 | Initiated | Leerink Partners | Outperform |
Apr-30-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
Apr-29-24 | Initiated | TD Cowen | Buy |
Mar-15-24 | Reiterated | Needham | Buy |
Sep-12-23 | Upgrade | Goldman | Neutral → Buy |
Mar-28-23 | Initiated | Goldman | Neutral |
Oct-28-22 | Initiated | Wedbush | Outperform |
Jul-28-22 | Resumed | B. Riley Securities | Buy |
Nov-02-21 | Initiated | Robert W. Baird | Outperform |
Feb-18-21 | Resumed | B. Riley Securities | Buy |
Aug-03-20 | Initiated | Stifel | Buy |
Nov-19-19 | Resumed | B. Riley FBR | Buy |
Sep-03-19 | Initiated | H.C. Wainwright | Buy |
Aug-15-19 | Initiated | Cantor Fitzgerald | Overweight |
Apr-09-19 | Upgrade | Needham | Hold → Buy |
Jan-31-19 | Upgrade | B. Riley FBR | Neutral → Buy |
Oct-02-18 | Downgrade | B. Riley FBR | Buy → Neutral |
Jul-05-18 | Initiated | B. Riley FBR, Inc. | Buy |
Sep-13-16 | Reiterated | FBR & Co. | Outperform |
Sep-13-16 | Reiterated | FBR Capital | Outperform |
Dec-07-15 | Reiterated | Piper Jaffray | Overweight |
Apr-21-15 | Initiated | Oppenheimer | Outperform |
Jun-12-14 | Upgrade | MLV & Co | Hold → Buy |
Mar-12-14 | Downgrade | MLV & Co | Buy → Hold |
Dec-10-13 | Reiterated | MLV & Co | Buy |
Dec-10-13 | Upgrade | Needham | Hold → Buy |
Nov-08-13 | Reiterated | MLV & Co | Buy |
Oct-16-13 | Initiated | MLV & Co | Buy |
Aug-30-12 | Initiated | Stifel Nicolaus | Buy |
Jun-28-12 | Initiated | Needham | Hold |
View All
Geron Corp Stock (GERN) Latest News
What earnings revisions data tells us about Geron CorporationSwing Trade & Risk Managed Investment Strategies - newser.com
Using data models to predict Geron Corporation stock movement2025 Major Catalysts & Capital Efficiency Focused Strategies - newser.com
What makes Geron Corporation stock attractive to growth fundsBreakout Watch & High Return Trade Guides - newser.com
Is Geron Corporation (GON) stock undervalued at current priceQuarterly Profit Review & High Accuracy Swing Entry Alerts - newser.com
Combining machine learning predictions for Geron CorporationMarket Trend Summary & Risk Managed Trade Strategies - newser.com
Long term hold vs stop loss in Geron CorporationQuarterly Profit Summary & Verified Momentum Stock Alerts - newser.com
Why Geron Corporation (GON) stock gets analyst attentionMarket Growth Summary & High Conviction Buy Zone Alerts - newser.com
Geron's (GERN) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)? - Yahoo Finance
Geron (NASDAQ:GERN) Stock Price Down 4.8%Here's Why - MarketBeat
How strong is Geron Corporation (GON) stock earnings growthDip Buying & Verified Swing Trading Watchlist - newser.com
Is Geron Corporation stock entering bullish territory2025 Investor Takeaways & Target Return Focused Picks - newser.com
Is Geron Corporation (GON) stock ideal for retirement investorsGDP Growth & Reliable Intraday Trade Plans - newser.com
Analyzing recovery setups for Geron Corporation investorsWeekly Trend Report & AI Enhanced Execution Alerts - newser.com
What MACD trends signal for Geron Corporation (GON) stock2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Building trade automation scripts for Geron CorporationPrice Action & Risk Managed Investment Signals - newser.com
Several Insiders Invested In Geron Flagging Positive News - simplywall.st
Geron Corp. Stock Hits Day High with Strong 7.87% Intraday Surge - Markets Mojo
Geron (NASDAQ:GERN) Stock Price Up 4.2%Should You Buy? - MarketBeat
Why institutional investors increase stakes in Geron Corporation (GON) stockPortfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Backtesting results for Geron Corporation trading strategies2025 Fundamental Recap & Daily Stock Momentum Reports - newser.com
Geron Corporation (NASDAQ:GERN) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Geron updates on Q4 revenue from U.S. sales of RYTELO - MSN
Nearly 1M Shares: Geron Corporation's Major Equity Grant Package Draws 16 New Biotech Talents - Stock Titan
Geron Corporation $GERN Shares Sold by Woodline Partners LP - MarketBeat
Aug Volume: What analysts say about Geron Corporation stockJuly 2025 Rallies & Daily Profit Focused Stock Screening - خودرو بانک
Geron Corporation $GERN Shares Purchased by Exome Asset Management LLC - MarketBeat
Graham Capital Management L.P. Purchases New Shares in Geron Corporation $GERN - MarketBeat
Edmond DE Rothschild Holding S.A. Grows Holdings in Geron Corporation $GERN - MarketBeat
Hsbc Holdings PLC Trims Holdings in Geron Corporation $GERN - MarketBeat
Geron Corp Stock (GERN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Geron Corp Stock (GERN) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Samuels Scott Alan | EVP, Chief Legal Officer |
Feb 27 '25 |
Buy |
1.61 |
15,000 |
24,150 |
26,682 |
SCARLETT JOHN A | Chairman, President and CEO |
Feb 27 '25 |
Buy |
1.76 |
12,500 |
22,062 |
12,500 |
Ziegler James | EVP, Chief Commercial Officer |
Feb 27 '25 |
Buy |
1.60 |
100,000 |
160,000 |
100,000 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):